Clinical implications of tumor-cell heterogeneity.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic; D004273:DNA, Neoplasm / Q000032:analysis; D004351:Drug Resistance; D005784:Gene Amplification; D014644:Genetic Variation; D006801:Humans; D007951:Leukemia, Myeloid / Q000235:genetics / Q000473:pathology; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000473:pathology*; D009857:Oncogenes; D010677:Philadelphia Chromosome
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm